pfizer inc (PFE:New York)
Amy W. Schulman
Director, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 115 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Ms. Amy W. Schulman served as an Executive Vice President and General Counsel of Pfizer Inc. from December 2010 to December 31, 2013 and June 23, 2008 respectively and served as its Business Unit Lead of Consumer Healthcare. Ms. Schulman served as the President and General Manager of Nutrition at Pfizer Inc. since December 2010. She served as an Executive Vice President and Business Unit Lead of Pfizer Nutrition at Pfizer Inc. since December 2010, Corporate Secretary ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*
Unknown/Other Education 1982
Yale Law School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|George W. Hebard III, M.B.A||Interim Principal Executive Officer, Interim Chief Operating Officer and Secretary|
Enzon Pharmaceuticals Inc.
|Mark J. Ahn Ph.D.||Chief Executive Officer, President and Director|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|